++
+++
Essentials of Diagnosis
++
Seen primarily in individuals from developing countries or immunocompromised patients
Back pain and gibbus deformity with radiographic evidence of vertebral involvement
Less than 20% of patients have active pulmonary tuberculosis
Evidence of Mycobacterium tuberculosis in aspirates or biopsies of spinal lesions
+++
General Considerations
++
Typically seen in adults who have immigrated from countries where tuberculosis is prevalent
May develop in the setting of immunosuppression (eg, HIV infection, therapy with biological agent)
Spinal tuberculosis accounts for ∼50% of musculoskeletal infection due to M tuberculosis
Seeding of the vertebrae may occur through
Hematogenous spread from the respiratory tract at the time of primary infection, with clinical disease developing years later as a consequence of reactivation
Lymphatics from infected foci in the pleura or kidneys
The thoracic and lumbar vertebrae are the most common sites of spinal involvement
Vertebral infection is associated with paravertebral cold abscesses in 75% of cases
++
Patients have back pain, often present for months and sometimes associated with radicular pain and lower extremity weakness
Constitutional symptoms are usually absent, and < 20% have active pulmonary disease
Destruction of the vertebral body anteriorly can produce the characteristic gibbus deformity
+++
Differential Diagnosis
++
All subacute and chronic spinal infections of bone, eg, pyrogenic organisms, Brucella, fungi
Malignancy
++
Most patients have a positive reaction to purified protein derivative (PPD) or a positive blood interferon-gamma release assay
Cultures of paravertebral abscesses and biopsies of vertebral lesions are positive in up to 70–90%
++
Radiographs can reveal lytic and sclerotic lesions and bony destruction of vertebrae but are normal early in the disease
CT scanning can demonstrate paraspinal soft tissue extensions of the infection
MRI is the imaging technique of choice to detect compression of the spinal cord or cauda equina
+++
Diagnostic Procedures
++
++
Antimicrobial therapy should be administered for 6–9 months, usually in the form of isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, followed by isoniazid and rifampin for an additional 4–7 months
Medical management alone is often sufficient
++